Systems biology of polycystic kidney disease: A critical review

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 7, Issue 1, 2015, Pages 39-52

  Menezes, Luis Fernando ^a   Germino, Gregory G ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIC KIDNEY DISEASE 2 PROTEIN; POLYCYSTIN; PROTEOME;

ANALYSIS; ARTICLE; COEXPRESSION NETWORK ANALYSIS; CONCEPTUAL FRAMEWORK; DATA ANALYSIS; DISEASE SEVERITY; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENOMICS; HUMAN; IN VIVO STUDY; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; METABOLOMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; SAMPLE SIZE; SYSTEMS BIOLOGY; ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; KIDNEY; METABOLISM; PROCEDURES;

ANIMALS; COMPUTER SIMULATION; HUMANS; KIDNEY; MODELS, BIOLOGICAL; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTEOME; SYSTEMS BIOLOGY; TRPP CATION CHANNELS;

EID: 84923205995     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.1289     Document Type: Article

References (59)

1. Barabási A, Oltvai Z. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113.
2. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12:56-68.
3. Neumann HP, Jilg C, Bacher J, Nabulsi Z, Malinoc A, Hummel B, Hoffmann MM, Ortiz-Bruechle N, Glasker S, Pisarski P, et al. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant 2013, 28:1472-1487.
4. Pei Y, Watnick T. Diagnosis and screening of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010, 17:140-152.
5. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996, 87:979-987.
6. Pei Y, Watnick T, He N, Wang K, Liang Y, Parfrey P, Germino G, St G-HP. Somatic PKD2 mutations in individual kidney and liver cysts support a 'two-hit' model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999, 10:1524-1529.
7. Gallagher AR, Germino GG, Somlo S. Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010, 17:118-130.
8. Watnick TJ, Germino GG. Polycystic kidney disease: polycystin-1 and polycystin-2--it's complicated. Nat Rev Nephrol 2013, 9:249-250.
9. Hanaoka K, Qian F, Boletta A, Bhunia A, Piontek K, Tsiokas L, Sukhatme V, Guggino W, Germino G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
10. Yamaguchi T, Pelling J, Ramaswamy N, Eppler J, Wallace D, Nagao S, Rome L, Sullivan L, Grantham J. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 2000, 57:1460-1471.
11. Lal M, Song X, Pluznick J, Di Giovanni V, Merrick D, Rosenblum N, Chauvet V, Gottardi C, Pei Y, Caplan M. Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 2008, 17:3105-3117.
12. Kim E, Arnould T, Sellin L, Benzing T, Fan M, Grüning W, Sokol S, Drummond I, Walz G. The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 1999, 274:4947-4953.
13. Bhunia A, Piontek K, Boletta A, Liu L, Qian F, Xu P, Germino F, Germino G. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002, 109:157-168.
14. Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek K, Germino G, Pandolfi P, Boletta A. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol Cell Biol 2009, 29:2359-2371.
15. Ma M, Tian X, Igarashi P, Pazour GJ, Somlo S. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet 2013, 45:1004-1012.
16. Menezes L, Germino G. Polycystic kidney disease, cilia, and planar polarity. Methods Cell Biol 2009, 94:273-297.
17. Piontek K, Menezes L, Garcia-Gonzalez M, Huso D, Germino G. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 2007, 13:1490-1495.
18. Babbage C. Passages from the Life of a Philosopher. New Brunswick, NJ: Rutgers University Press; 1994.
19. Joly D, Morel V, Hummel A, Ruello A, Nusbaum P, Patey N, Noël LH, Rousselle P, Knebelmann B. β4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. Am J Pathol 2003, 163:1791-1800.
20. Husson H, Manavalan P, Akmaev V, Russo R, Cook B, Richards B, Barberio D, Liu D, Cao X, Landes G, et al. New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics 2004, 84:497-510.
21. Schieren G, Rumberger B, Klein M, Kreutz C, Wilpert J, Geyer M, Faller D, Timmer J, Quack I, Rump LC, et al. Gene profiling of polycystic kidneys. Nephrol Dial Transplant 2006, 21:1816-1824.
22. Riera M, Burtey S, Fontés M. Transcriptome analysis of a rat PKD model: importance of genes involved in extracellular matrix metabolism. Kidney Int 2006, 69:1558-1563.
23. Allen E, Piontek K, Garrett-Mayer E, Garcia-Gonzalez M, Gorelick K, Germino G. Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors. Hum Mol Genet 2006, 15:11-21.
24. Wallace DP, Quante MT, Reif GA, Nivens E, Ahmed F, Hempson SJ, Blanco G, Yamaguchi T. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through αV-integrin receptor. Am J Physiol Renal Physiol 2008, 295:F1463-F1471.
25. Chen W, Tzeng Y, Li H. Gene expression in early and progression phases of autosomal dominant polycystic kidney disease. BMC Res Notes 2008, 1:131.
26. Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum N, Pei Y. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 2009, 18:2328-2343.
27. Kugita M, Nishii K, Morita M, Yoshihara D, Kowa-Sugiyama H, Yamada K, Yamaguchi T, Wallace D, Calvet J, Kurahashi H, et al. Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling. Am J Physiol Renal Physiol 2010, 300:F177-F178.
28. Park EY, Seo MJ, Park JH. Effects of specific genes activating RAGE on polycystic kidney disease. Am J Nephrol 2010, 32:169-178.
29. Pandey P, Qin S, Ho J, Zhou J, Kreidberg JA. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease. BMC Syst Biol 2011, 5:56.
30. Menezes LF, Zhou F, Patterson AD, Piontek KB, Krausz KW, Gonzalez FJ, Germino GG. Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease modifier. PLoS Genet 2012, 8:e1003053.
31. Boehn SN, Spahn S, Neudecker S, Keppler A, Bihoreau MT, Kränzlin B, Pandey P, Hoffmann SC, Li L, Torres VE, et al. Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat. Nephrol Dial Transplant 2013, 28:2045-2058.
32. Dweep H, Sticht C, Kharkar A, Pandey P, Gretz N. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model. PLoS One 2013, 8:e53780.
33. Ioannidis JP, Allison DB, Ball CA, Coulibaly I, Cui X, Culhane AC, Falchi M, Furlanello C, Game L, Jurman G, et al. Repeatability of published microarray gene expression analyses. Nat Genet 2009, 41:149-155.
34. Liu Y, Dai B, Mei C, Zhang Y, Xiong X, Sandford R. Identification of phosphoproteins in kidney tissues from patients with autosomal dominant polycystic kidney disease. Proteomics Clin Appl 2008, 2:1153-1166.
35. Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, Witzmann FA. Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl 2008, 2:1140-1152.
36. Lai X, Blazer-Yost BL, Gattone VH, Muchatuta MN, Witzmann FA. Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease. Proteomics 2009, 9:3775-3782.
37. Kistler AD, Mischak H, Poster D, Dakna M, Wüthrich RP, Serra AL. Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease. Kidney Int 2009, 76:89-96.
38. Hogan MC, Manganelli L, Woollard JR, Masyuk AI, Masyuk TV, Tammachote R, Huang BQ, Leontovich AA, Beito TG, Madden BJ, et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol 2009, 20:278-288.
39. Mason SB, Lai X, Bacallao RL, Blazer-Yost BL, Gattone VH, Wang KC, Witzmann FA. The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid. Proteomics Clin Appl 2009, 3:1247-1250.
40. Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Böger CA, Banas B, Eckardt KU, et al. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int 2011, 79:1244-1253.
41. Bakun M, Niemczyk M, Domanski D, Jazwiec R, Perzanowska A, Niemczyk S, Kistowski M, Fabijanska A, Borowiec A, Paczek L, et al. Urine proteome of autosomal dominant polycystic kidney disease patients. Clin Proteomics 2012, 9:13.
42. Kistler AD, Serra AL, Siwy J, Poster D, Krauer F, Torres VE, Mrug M, Grantham JJ, Bae KT, Bost JE, et al. Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One 2013, 8:e53016.
43. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
44. Taylor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol 2010, 298:F909-F922.
45. Toyohara T, Suzuki T, Akiyama Y, Yoshihara D, Takeuchi Y, Mishima E, Kikuchi K, Suzuki C, Tanemoto M, Ito S, et al. Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clin Exp Nephrol 2011, 15:676-687.
46. Abbiss H, Maker GL, Gummer J, Sharman MJ, Phillips JK, Boyce M, Trengove RD. Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease. Nephrology (Carlton) 2012, 17:104-110.
47. Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M, Song XW, Xu H, Mari S, Qian F, et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med 2013, 19:488-493.
48. Carroll L. Sylvie and Bruno Concluded. London; New York: MacMillan and Co; 1893.
49. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform 2008, 9:559.
50. Oliveri P, Davidson E. Gene regulatory network analysis in sea urchin embryos. Methods Cell Biol 2004, 74:775-794.
51. Popper K. The Logic of Scientific Discovery. London: Routledge; 1959 (reprinted 2002).
52. Stamos DN. Popper, laws, and the exclusion of biology from genuine science. Acta Biotheor 2007, 55:357-375.
53. Dougherty ER. Validation of gene regulatory networks: scientific and inferential. Brief Bioinform 2011, 12:245-252.
54. Yuan S, Sun Z. Expanding horizons: ciliary proteins reach beyond cilia. Annu Rev Genet 2013, 47:353-376.
55. Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peränen J, Merdes A, Slusarski DC, Scheller RH, Bazan JF, Sheffield VC, et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 2007, 129:1201-1213.
56. Payne JL, Wagner A. The robustness and evolvability of transcription factor binding sites. Science 2014, 343:875-877.
57. Sun Z, Amsterdam A, Pazour GJ, Cole DG, Miller MS, Hopkins N. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 2004, 131:4085-4093.
58. Mangos S, Lam PY, Zhao A, Liu Y, Mudumana S, Vasilyev A, Liu A, Drummond IA. The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation. Dis Model Mech 2010, 3:354-365.
59. Nuzzo R. Scientific method: statistical errors. Nature 2014, 506:150-152.